Submit Feedback Join the Alliance


ANNOUNCEMENT



The Nanomedicines Alliance is pleased to announce that AstraZeneca joined as a new member in January 2014. The full list of members can be found under the Members tab.



VISION AND MISSION



As the only industry group in existence that focuses on the scientific and regulatory aspects and policy needs of nanomedicines, the Alliance has the following vision and mission:

Vision

To catalyze the use of nanomedicines for patient benefit.

Mission

To promote and facilitate the scientific advancement, regulatory approval, safe use and public appreciation of nanotechnology-based medicines world-wide for the diagnosis, treatment and prevention of disease.

Scope

The scope of the Alliance includes nanomaterials and nanotechnologies involved in the discovery, research, development, testing, manufacturing, marketing and disposal of pharmaceuticals, biologics and medical devices, including imaging and diagnostics.

STRATEGY FRAMEWORK